Open access
1,047
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer
Autologous engineered T cell receptor therapy in advanced cancer
Apostolia M. Tsimberidoua Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
https://orcid.org/0000-0003-2713-233XView further author information
Mehmet A. Baysala Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
https://orcid.org/0000-0002-8446-6531View further author information
Abhijit Chakrabortya Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
https://orcid.org/0000-0002-3822-5657View further author information
Borje S. Anderssonb Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
https://orcid.org/0000-0003-4761-0220View further author information
Article: 2290356
|
Received 29 Sep 2023, Accepted 29 Nov 2023, Published online: 19 Dec 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.